WHO says hydroxychloroquine coronavirus trials to resume

The World Health Organization says clinical trials of the drug hydroxychloroquine will resume, having been suspended pending a safety review in the search for coronavirus treatments.

“On the basis of the available mortality data… the executive group will communicate with the principal investigators in the trial about resuming the hydroxychloroquine arm,” WHO chief Tedros Adhanom Ghebreyesus tells a virtual news briefing.

In this photo taken on March 11, 2020, World Health Organization Director-General Tedros Adhanom Ghebreyesus attends a daily press briefing on COVID-19, at the WHO headquarters in Geneva. (Fabrice COFFRINI / AFP)

— AFP

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.